by The Kopi Notes | Nov 17, 2026 | ETFs
Year-End ETF Portfolio Rebalancing for Singapore Investors (2026 Guide) SRS deadlines, CPF caps, and a step-by-step SGD rebalancing example for the final weeks of 2026. Year-end ETF portfolio rebalancing means bringing a drifted allocation back to its target weights...
by The Kopi Notes | Nov 15, 2026 | ETFs
STI ETF vs CSPX: Should Singapore Investors Go Local or Global? (2026) Comparing fees, CPF/SRS access and returns between Singapore’s home-grown STI ETF and the LSE-listed CSPX. The STI ETF (ES3 or G3B) tracks 30 Singapore blue chips and is CPF-OA and SRS...
by The Kopi Notes | Nov 14, 2026 | ETFs
How to Dollar-Cost Average Into CSPX in Singapore (2026 Guide) Monthly investment plans compared: FSM Global RSP, IBKR Recurring Investments, moomoo and Syfe. Singapore investors can dollar-cost average (DCA) into CSPX — the iShares Core S&P 500 UCITS ETF —...
by The Kopi Notes | Nov 13, 2026 | ETFs
CSPX vs IWDA: S&P 500 or MSCI World for Singapore Investors? (2026) Both are Ireland-domiciled, LSE-listed UCITS ETFs with the same tax treatment — the real choice is concentration vs diversification. CSPX tracks the S&P 500 (100% US large caps, TER 0.07%)...
by The Kopi Notes | Nov 12, 2026 | ETFs
S&P 500 ETF Sell-Off: Should Singapore Investors Buy the Dip With CSPX? (November 2026) The S&P 500 just had its worst day since April 2025. Here’s what actually happened, what it means for CSPX holders, and how a Singapore investor might think about...
by The Kopi Notes | Nov 11, 2026 | ETFs
Why Singapore Investors Buy ETFs on the London Stock Exchange (2026 Guide) The tax mechanics behind why CSPX, VWRA and other LSE-listed ETFs are the default choice for Singapore investors over US-listed equivalents like VOO or SPY. Singapore investors buy ETFs listed...